. Author manuscript; available in PMC: 2015 Jun 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2014 Feb 16;20(6):787–793. doi: 10.1016/j.bbmt.2014.02.010

Table 4. Comparison of HHV-6 viremia kinetics in 110 patients in whom HHV6 viremia was either observed or treated with foscarnet.

HHV-6 Characteristics	Observed Patients (n = 79) (Median, range)	Treated Patients (n = 31) (Median, range)

Onset	20 days (10-40)	19 days (10-56)
Peak (copies/ml)	3,800 (100-148,000)	24,100 (2,000-160,000)
Day of Peak	23 days (12-42)	21 days (14-57)
Foscarnet Onset	-	24 days (17-83)
Foscarnet Duration	-	9 days (1-22)
Viremia Duration^*	9 days (1-49)	8 days (1-60)

Reflects number of days from first to last positive.